Clinical Trial Update: Comparison of Doravirine, Tenofovir, Lamivudine (MK-1439A) and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing doravirine/tenofovir disoproxil fumarate/lamivudine (MK-1439A-021) with ATRIPLA in treatment-naive HIV-1-infected partic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate)
• Doravirine (doravirine)
• Lamivudine (lamivudine)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Human Immunodeficiency Virus (HIV) | Phase 3 | Status: COMPLETED | Results posted: 2018-04-30